Indolo isoquinoline compounds
    33.
    再颁专利
    Indolo isoquinoline compounds 失效
    吲哚异喹啉化合物

    公开(公告)号:USRE31194E

    公开(公告)日:1983-03-29

    申请号:US293588

    申请日:1981-08-17

    摘要: Isoquinoline compounds of the following formula are described: ##STR1## wherein the moiety A-B represents a group of formula:--CH.sub.2 --NR.sup.3 -- or --NR.sup.3 --CH.sub.2 --;wherein R.sup.3 represents hydrogen, C.sub.1-6 alkyl, C.sub.3-6 cycloalkyl C.sub.3-6 cycloalkyl-C.sub.1-4 alkyl, optionally substituted benzyl, C.sub.3-6 alkenyl or C.sub.1-4 alkanoyl;wherein R represents hydrogen, C.sub.1-6 alkyl, C.sub.3-6 cycloalkyl, or optionally substituted benzyl;wherein R.sup.1 and R.sup.2 each represent hydrogen or taken together represent a chemical bond; and wherein X is hydrogen or halogen; or an acid-addition salt thereof.The compounds are pharmaceuticals and especially useful in the treatment of disorders of the central nervous system.

    摘要翻译: 描述下式的异喹啉化合物:其中A-B部分代表式-CH 2 -NR 3 - 或-NR 3 -CH 2 - 基团; 其中R 3表示氢,C 1-6烷基,C 3-6环烷基C 3-6环烷基-C 1-4烷基,任选取代的苄基,C 3-6烯基或C 1-4烷酰基; 其中R表示氢,C 1-6烷基,C 3-6环烷基或任选取代的苄基; 其中R1和R2各自表示氢或一起代表化学键; 并且其中X是氢或卤素; 或其酸加成盐。 这些化合物是药物,特别可用于治疗中枢神经系统疾病。